Opioid free anaesthesia
Phase 4
- Conditions
- Health Condition 1: C579- Malignant neoplasm of female genital organ, unspecified
- Registration Number
- CTRI/2022/12/048126
- Lead Sponsor
- niversity College of Medical sciences and GTB Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consenting ASA grade I-II patients,aged 20-65 years, undergoing exploratory laparotomy for gynaecological cancer surgeries.
Exclusion Criteria
Patients with history of any etiology , postoperative nausea and vomiting,prior allergy to local anaesthetics or coagulopathies, patients receiving opioids and patients having inability to comprehend questionnaires
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of recovery QoR 40 score at 12th hr day 1 & day 3Timepoint: Quality of recovery QoR 40 score at 12th hr day 1 & day 3
- Secondary Outcome Measures
Name Time Method To determine the pain intensity in the immediate postoperative period till day 3 <br/ ><br> <br/ ><br>To determine the rescue analgesic consumption in first 24 hrs <br/ ><br> <br/ ><br>To determine PONV scores in the immediate postoperative period in first 24 hrs <br/ ><br> <br/ ><br>To assess the neuropathic component of pain via DN-4 questionnaire.Timepoint: To determine the pain intensity in the immediate postoperative period till day 3 <br/ ><br> <br/ ><br>To determine the rescue analgesic consumption in first 24 hrs <br/ ><br> <br/ ><br>To determine PONV scores in the immediate postoperative period in first 24 hrs <br/ ><br> <br/ ><br>To assess the neuropathic component of pain via DN-4 questionnaire.